BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 29269007)

  • 41. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
    Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
    J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain Metastases.
    Jiang T; Su C; Li X; Zhao C; Zhou F; Ren S; Zhou C; Zhang J
    J Thorac Oncol; 2016 Oct; 11(10):1718-28. PubMed ID: 27237825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison Between Surgical Resection and Stereotactic Radiosurgery in Patients with a Single Brain Metastasis from Non-Small Cell Lung Cancer.
    Bougie E; Masson-Côté L; Mathieu D
    World Neurosurg; 2015 Jun; 83(6):900-6. PubMed ID: 25659803
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis.
    Hu C; Chang EL; Hassenbusch SJ; Allen PK; Woo SY; Mahajan A; Komaki R; Liao Z
    Cancer; 2006 May; 106(9):1998-2004. PubMed ID: 16572401
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
    Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
    J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiological Features of Brain Metastases from Non-small Cell Lung Cancer Harboring
    Takamori S; Toyokawa G; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Mukae N; Hirai F; Tagawa T; Oda Y; Iwaki T; Iihara K; Honda H; Maehara Y
    Anticancer Res; 2018 Jun; 38(6):3731-3734. PubMed ID: 29848735
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of three treatment options for single brain metastasis from lung cancer.
    Li B; Yu J; Suntharalingam M; Kennedy AS; Amin PP; Chen Z; Yin R; Guo S; Han T; Wang Y; Yu N; Song G; Wang L
    Int J Cancer; 2000 Feb; 90(1):37-45. PubMed ID: 10725856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcome of stereotactic radiosurgery for patients with non-small cell lung cancer metastatic to the brain.
    Mariya Y; Sekizawa G; Matsuoka Y; Seki H; Sugawara T
    J Radiat Res; 2010; 51(3):333-42. PubMed ID: 20383028
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of brain metastases from non-small cell lung cancer.
    Baykara M; Kurt G; Buyukberber S; Demirci U; Ceviker N; Algin E; Coskun U; Aykol S; Emmez H; Ozet A; Benekli M
    J Cancer Res Ther; 2014; 10(4):915-21. PubMed ID: 25579528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Five-fraction stereotactic radiosurgery (SRS) for single inoperable high-risk non-small cell lung cancer (NSCLC) brain metastases.
    Lischalk JW; Oermann E; Collins SP; Nair MN; Nayar VV; Bhasin R; Voyadzis JM; Rudra S; Unger K; Collins BT
    Radiat Oncol; 2015 Oct; 10():216. PubMed ID: 26503609
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of ALK inhibitors on NSCLC brain metastases: A systematic review and pooled analysis of 21 studies.
    Petrelli F; Lazzari C; Ardito R; Borgonovo K; Bulotta A; Conti B; Cabiddu M; Capitanio JF; Brighenti M; Ghilardi M; Gianni L; Barni S; Gregorc V
    PLoS One; 2018; 13(7):e0201425. PubMed ID: 30052658
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relevance of gamma knife radiosurgery alone for the treatment of non-small cell lung cancer brain metastases.
    Zairi F; Ouammou Y; Le Rhun E; Aboukais R; Blond S; Vermandel M; Deken V; Devos P; Reyns N
    Clin Neurol Neurosurg; 2014 Oct; 125():87-93. PubMed ID: 25108698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Individualized early death and long-term survival prediction after stereotactic radiosurgery for brain metastases of non-small cell lung cancer: Two externally validated nomograms.
    Zindler JD; Jochems A; Lagerwaard FJ; Beumer R; Troost EGC; Eekers DBP; Compter I; van der Toorn PP; Essers M; Oei B; Hurkmans CW; Bruynzeel AME; Bosmans G; Swinnen A; Leijenaar RTH; Lambin P
    Radiother Oncol; 2017 May; 123(2):189-194. PubMed ID: 28237400
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The strategy of repeat stereotactic radiosurgery without whole brain radiation treatment for new brain metastases: Outcomes and implications for follow-up monitoring.
    Shen CJ; Rigamonti D; Redmond KJ; Kummerlowe MN; Lim M; Kleinberg LR
    Pract Radiat Oncol; 2016; 6(6):409-416. PubMed ID: 27687187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gamma knife radiosurgery for patients with brain metastases from non-small cell lung cancer: Comparison of survival between <5 and ≥5 metastases.
    Zhao X; Ding S; Zhang M; Wang C
    Thorac Cancer; 2022 Aug; 13(15):2152-2157. PubMed ID: 35770337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gamma knife treatment for multiple metastatic brain tumors compared with whole-brain radiation therapy.
    Serizawa T; Iuchi T; Ono J; Saeki N; Osato K; Odaki M; Ushikubo O; Hirai S; Sato M; Matsuda S
    J Neurosurg; 2000 Dec; 93 Suppl 3():32-6. PubMed ID: 11143259
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic Impact of Histologic Subtype in Non-Small Cell Lung Cancer Patients Treated with Gamma Knife Radiosurgery: Retrospective Analysis of 104 Patients.
    Aydemir F; Tufan K; Cekinmez M; Kardes O; Sarica FB; Topkan E; Sonmez E; Alkan O; Ugurluer G; Altinors N
    Turk Neurosurg; 2017; 27(1):14-21. PubMed ID: 27593758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Time for reappraisal of extracranial treatment options? Synchronous brain metastases from nonsmall cell lung cancer.
    Lind JS; Lagerwaard FJ; Smit EF; Postmus PE; Slotman BJ; Senan S
    Cancer; 2011 Feb; 117(3):597-605. PubMed ID: 20872880
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship between WBRT total dose, intracranial tumor control, and overall survival in NSCLC patients with brain metastases - a single-center retrospective analysis.
    Li Z; Shen D; Zhang J; Zhang J; Yang F; Kong D; Kong J; Zhang A
    BMC Cancer; 2019 Nov; 19(1):1104. PubMed ID: 31727054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.